healthcare

Tom Delic, assistant fund manager at Seneca Investment Managers explores the demographic trends - from opportunities in tech to wealth management - that are available for investors to take advantage of

Tough 12 months

The Merchants trust's Simon Gergel explains why investing in one of the UK's biggest healthcare stocks - GlaxoSmithKline - is not as simple as many investors envisage

Hardeep Tawakley takes a closer look at the evolution of specialist funds and speaks to buyers about their favourite offerings.

Rising rates also a boost

Equities already entered a bear market

Oil, industrials and banks dividends at risk

Costs "unsustainable"

Focus on ESG

Keith Barrett, head of research at Ingenious Asset Management, asks whether outperformance in US healthcare stocks can continue or if it is time to take profits.